
Weyerhaeuser (WY)
NYSEReal EstateReit - SpecialtySnapshot 2026-07-07
Reading WY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track WY free→
NYSEReal EstateReit - SpecialtySnapshot 2026-07-07
Reading WY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track WY free→QuarterlyIQ Insights · WY
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. Current price $23.29. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $23 WY trades at 19× p/ffo, in line with its 16× p/ffo peer median — but our blended $14 fair value sits well below the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Mania regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/FFO | 12M | $20.29 | 16.2 | 1.25 | TTM | high |
| Peer P/S | 12M | $75.54 | 7.9 | 9.52 | TTM | high |
| Own P/E history | 12M | $11.53 | 57.6 | 0.20 | TTM | high |
| triangulated | 12M | $3.55 | 16.2 | 0.22 | Triangulated | high |
| Peer P/FFO | 3Y | $10.52 | 16.2 | 0.65 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $93.75 | 7.9 | 11.81 | Analyst | medium |
| Own P/E history | 3Y | $59.57 | 57.6 | 1.03 | Hist. CAGR(prov.) | medium |
| Peer P/FFO | 5Y | $6.79 | 16.2 | 0.42 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $107.93 | 7.9 | 13.60 | Analyst | high |
| Own P/E history | 5Y | $68.58 | 57.6 | 1.19 | Hist. CAGR(prov.) | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.